Figure 3.

The Kaplan-Meier plots showing maintenance of remission in two groups of patients receiving GMA or PSL. Patients who achieved remission (CAIā‰¤4) at the end of the active treatment period (arrow head) were followed to monitor maintenance of remission. As shown, no significant (ns) difference between the two groups was found with respect to maintenance of clinical remission at the end of the follow-up time (600 days).

Tominaga et al. BMC Gastroenterology 2013 13:41   doi:10.1186/1471-230X-13-41
Download authors' original image